Efficacy of Nebido on Bone Mineral Density (BMD) in Hypogonadal Paraplegic Patients With Confirmed Osteoporosis
Status:
Completed
Trial end date:
2009-05-01
Target enrollment:
Participant gender:
Summary
Both conditions hypogonadism and immobilisation (paraplegia) may contribute or lead to
decreased bone mineral density resp osteoporosis. In this study bone mineral density is
assessed in hypogonadal paraplegic patients, who are on standard prophylactic therapy for
osteoporosis and and on a standard physiotherapy exercise program one group receiving Nebido
for testosterone replacement (TRT). The additional effect of TRT on bone mineral density /
osteoporosis is assessed (CT scan lumbar spine).